DrugPatentWatch Database Preview
Details for Patent: 10,471,053
» See Plans and Pricing
Which drugs does patent 10,471,053 protect, and when does it expire?
Patent 10,471,053 protects GALAFOLD and is included in one NDA.
This patent has forty-nine patent family members in twenty-three countries.
Summary for Patent: 10,471,053
| Title: | Methods of treating Fabry patients having renal impairment |
| Abstract: | Provided are methods for treatment of Fabry disease in patients having HEK assay amenable mutations in .alpha.-galactosidase A. Certain methods comprise administering migalastat or a salt thereof every other day, such as administering about 150 mg of migalastat hydrochloride every other day. |
| Inventor(s): | Castelli; Jeff (New Hope, PA), Benjamin; Elfrida (Millstone Township, NJ) |
| Assignee: | Amicus Therapeutics, Inc. (Cranbury, NJ) |
| Application Number: | 16/284,582 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,471,053
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Theraps Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | Start Trial | Start Trial | THE TREATMENT OF FABRY PATIENTS | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,471,053
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 111971 | Start Trial | |||
| Australia | 2009214648 | Start Trial | |||
| Australia | 2014221321 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
